Pharming, Aslan Group sign lactoferrin deal
This article was originally published in The Tan Sheet
Executive Summary
The Netherlands-based biotech firm Pharming Group licenses Istanbul, Turkey-based Aslan to develop, manufacture and market Pharming's human lactoferrin product, which is in "late stage development" for use in food products, Pharming says Nov. 18. Pharming breeds "experimental herds" of cows to produce milk with human lactoferrin, a protein in mammals. Under the 10-year agreement, Aslan will pay sales royalties to Pharming while it has exclusive marketing rights to produce hLF with Pharming's technology and sells food and supplements with the ingredient in Turkey, the Middle East, Russia and other areas. Aslan will pay 20 million euros ($25.2 milliion dollars under Nov. 18 conversion rates) in licensing fees in the next three years
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.